MEC Plus

New Therapeutic Directions in Lung Cancer
New Therapeutic Directions in Lung Cancer
Jonathan W. Riess, MD
Updates in Genitourinary Cancers
Updates in Genitourinary Cancers
Mamta Parikh, MD, MS
Cancer-related Bleeding and Thrombosis
Cancer-related Bleeding and Thrombosis
Anjlee Mahajan, MD
State of the Art in Acute Leukemias
State of the Art in Acute Leukemias
Brian A. Jonas, MD, PhD
Late Recurrences in ER Positive Breast Cancer: The Next Frontier?
Late Recurrences in ER Positive Breast Cancer: The Next Frontier?
Daniel F. Hayes, MD
Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise
Liquid Biopsies in Breast Cancer: Fact, Fiction, and Promise
Daniel F. Hayes, MD
Updates in Sarcoma Therapies
Updates in Sarcoma Therapies
Janai Carr-Ascher, MD, PhD
State of the Art in Gynecologic Oncology
State of the Art in Gynecologic Oncology
Rebecca A. Brooks, MD
Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers
Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers
May Cho, MD
Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020
Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020
David R. Gandara, MD
Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether to Permanently Stop or Not
Case Presentation - Lung - Immunotherapy Toxicity Case, How to Manage and Whether to Permanently Stop or Not
Helen Shih
Immunotherapy selection in mRCC
Immunotherapy selection in mRCC
Sandy Srinivas. MD
Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care
Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care
J. Marie Suga, MD
Triple-negative and Hereditary Breast Cancer
Triple-negative and Hereditary Breast Cancer
Melinda Telli, M.D.
A Case Presentation in Metastatic Breast Cancer - Opportunities for Immunotherapy
A Case Presentation in Metastatic Breast Cancer - Opportunities for Immunotherapy
Laura Quintal
HER+, ER+, San Antonio Update
HER+, ER+, San Antonio Update
Mark D. Pegram, M.D.
Non-Clear Cell RCC - Emerging Approaches
Non-Clear Cell RCC - Emerging Approaches
Primo N. Lara
Targeted Therapy
Targeted Therapy
Matthew Gubens, MD
Promising Immunotherapy for Melanoma
Promising Immunotherapy for Melanoma
Sanjiv S. Agarwala, MD
Immunotherapy & Targeted Therapy in Melanoma
Immunotherapy & Targeted Therapy in Melanoma
Sanjiv S. Agarwala, MD
Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA
Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA
John T. Cole MD
Case Presentation - Breast
Case Presentation - Breast
Sukhmani K Gill, MD
Lung Cancer Immunotheraphy Case Presentation
Lung Cancer Immunotheraphy Case Presentation
Yasmin Hajja, MD
Immunotherapy in Breast
Immunotherapy in Breast
Mohammad Jahanzeb, MD
Case Presentation - GU
Case Presentation - GU
Alex Niu
Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK
Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK
Janakiraman Subramanian MD
Immunotherapy in Lung Cancer
Immunotherapy in Lung Cancer
Edgardo S. Santos Castillero, M.D
Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1
Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1
Luis E. Raez MD
Targeted Therapy in Prostate
Targeted Therapy in Prostate
Alan J. Koletsky, MD